Oncologists (doctors specializing in cancer) assign a stage to multiple myeloma to express how advanced the cancer is and their prediction for how it will progress. Recommendations about myeloma treatment are based partly on the stage. Two different systems are used to stage multiple myeloma. Both systems recognize three stages and are based on the results of clinical tests rather than myeloma symptoms a person experiences.
Some doctors regard related precancerous conditions, such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), as early, asymptomatic stages of multiple myeloma. However, this article deals with how cancer is staged when multiple myeloma is first diagnosed or when it relapses.
Read more about myeloma types and related disorders.
There are two staging systems for multiple myeloma, the International Staging System (ISS) and the Durie-Salmon Staging System. Each is based on measurements of different properties.
The International Staging System was introduced in 2003, and many doctors consider it a more accurate assessment of the risk for multiple myeloma progression. The ISS does not take X-rays or bone lesions into account when staging multiple myeloma. Oncologists using the ISS perform a cytogenetic study to examine the genes of cancer cells for traits connected with a high risk for progression. They also measure levels of different substances found in the blood, including albumin (a common protein), beta microglobulin (protein produced by myeloma cells), and lactate dehydrogenase (an enzyme produced as cells turn glucose into energy).
Read more about stage 1 multiple myeloma.
Read more about stage 2 multiple myeloma.
Read more about stage 3 multiple myeloma.
First introduced in the 1970s, the Durie-Salmon staging system is still used by some doctors to stage multiple myeloma. Oncologists using the Durie-Salmon system look at X-rays and count bone lesions. They also test blood and urine to measure levels of hemoglobin (a protein that transports oxygen in the blood), calcium (a mineral released when bones are breaking down), and M proteins and light chains (abnormal fragments of antibodies made by the immune system).
If there is a relapse after multiple myeloma has been effectively treated, the oncologist may re-stage the cancer based on the same criteria.
Condition Guide
Get updates directly to your inbox.
If Dr Tells U That Ur In Partial Remission And Your Numbers Are Excellent Should U Still Be Getting Chemo 3 Times A Month
Stage 4 Lung Cancer Caused Many Symptoms That Reduce Food Intake And Cause Vomiting And Weight Loss In My Chinese Wife.
Can One Do Anything About Raised Creatine Levels? I Am Worried About My Kidneys. Liz 2
For High-risk SMM, My Oncologist Recommends RVd Treatment. At Age 77, QoL Is More Important Than Quantity. What If I Reject Treatment?
What Happened If Myeloma Untreated
What Is MGUS Classified As With Multiple Myloma?
At What Time Should You Be Worried When You’re Under Supervision For MGUS?
Become a member to get even more:
A MyMyelomaTeam Member
in Australia we do not discuss stages and our drugs differ as well as which specialist is the head of the bunch
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.